SS
Shelley Sardul Singh
Intellia Therapeutics (United States), CSIR - Institute of Microbial Technology
0009-0008-0806-8196
Employment
-
Intellia Therapeutics (United States)
Education
-
CSIR - Institute of Microbial Technology PhD
Projects & Funding
Projects & funding information is unavailable.
Publications (10)
- The role of amino acid composition in the antibacterial activity of laterosporulin analogs Save
- Antimicrobial Compounds from Anaerobic Microorganisms: A Review of an Untapped Reservoir Save
- Brevicillin, a novel lanthipeptide from the genusBrevibacilluswith antimicrobial, antifungal, and antiviral activity Save
- Characterization of Iturin V, a Novel Antimicrobial Lipopeptide from a Potential Probiotic Strain Lactobacillus sp. M31 Save
- Characterization and Antimicrobial Studies of Iturin-Like and Bogorol-Like Lipopeptides From Brevibacillus spp. Strains GI9 and SKDU10 Save
- Surfactin Like Broad Spectrum Antimicrobial Lipopeptide Co-produced With Sublancin From Bacillus subtilis Strain A52: Dual Reservoir of Bioactives Save
- Hungatella Save
- Virgicin, a novel lanthipeptide from Virgibacillus sp. strain AK90 exhibits inhibitory activity against Gram-positive bacteria Save
- Identification of Guanosine 5′-diphosphate as Potential Iron Mobilizer: Preventing the Hepcidin-Ferroportin Interaction and Modulating the Interleukin-6/Stat-3 Pathway Save
- Biocatalytic potential of lipase from Staphylococcus sp. MS1 for transesterification of jatropha oil into fatty acid methyl esters Save